Evidence map›Paper›PMID 16157890›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2005

The anti-tetanus immune response of neonatal mice is augmented by retinoic acid combined with polyriboinosinic:polyribocytidylic acid.

Yifan Ma, A Catharine Ross

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Potential for use of retinoic acid as an oral vaccine adjuvant.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2015
    Review
  13. Article
  14. Article
  15. Article
  16. β-Carotene Biosynthesis in Probiotic Bacteria.Probiotics and antimicrobial proteins · 2013
    Article
  17. Vitamin A and retinoic acid in T cell-related immunity.The American journal of clinical nutrition · 2012
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yifan MaGraduate Program in Integrative Biosciences, Huck Institute for Life Sciences, Pennsylvania State University, University Park, PA 16802, USA.
A Catharine Ross
Pennsylvania State University · US

Funding

VITAMIN A NUTRITIONAL STATUS AND IMMUNE FUNCTIONR01DK041479 · NIDDK · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI ROSS, A. CATHARINE · 1989 to 2015
$4.0M
NIDDK NIH HHS R01 DK041479NIDDK NIH HHS R01 DK-41479
6 · The paper itself

Abstract

Neonates are highly susceptible to infectious diseases and, in general, respond poorly to conventional vaccines due to immaturity of the immune system. In the present study, we hypothesized that the anti-tetanus toxoid (TT) vaccine response of neonatal mice could be enhanced by retinoic acid (RA), a bioactive retinoid, and polyriboinosinic:polyribocytidylic acid (PIC), an inducer of IFN. Early-life treatments with RA and/or PIC were well tolerated and stimulated both primary anti-TT IgG production in infancy and the memory response in adulthood. TT-specific lymphocyte proliferation and type 1/type 2 cytokine production were also significantly augmented. In addition, RA and PIC modulated the maturation and/or differentiation of neonatal B cells, natural killer (NK)/NKT cells, and antigen-presenting cells. Although RA alone increased the neonatal anti-TT antibody response, it selectively increased anti-TT IgG1 and IL-5, resulting in a skewed type 2 response. PIC, a potent adjuvant in adult mice, elevated neonatal anti-TT IgG as well as all IgG isotypes (IgG1, IgG2a, and IgG2b) and induced TT-specific IFN-gamma, an important type 1 cytokine; however, PIC alone failed to benefit the memory response. The combination of RA plus PIC was more potent than either agent alone in elevating primary and secondary anti-TT IgG responses as well as IgG isotypes. Moreover, RA plus PIC increased TT-specific IFN-gamma and IL-5, suggesting the combination effectively promoted both type 1 and type 2 responses in neonatal mice. Thus, RA combined with PIC, a nutritional-immunological intervention, seems promising as an adjuvant for early-life vaccination.

Indexed as

Adjuvants, ImmunologicAnimalsAnimals, NewbornAntineoplastic AgentsDose-Response Relationship, ImmunologicHumansImmunoglobulin GInfant, NewbornInterferon-gammaInterferon InducersInterleukin-5LymphocytesMicePoly I-CTetanus ToxoidTretinoinAdjuvants, ImmunologicAntineoplastic AgentsImmunoglobulin GInterferon-gammaInterferon InducersInterleukin-5Poly I-CTetanus ToxoidTretinoin

Identifiers

PMID16157890
PMCPMC1224655
OpenAlexW2103579333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.